<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/allregs/css/uswds.min.css">
    <link rel="stylesheet" href="/allregs/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/allregs/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/allregs/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/parts/21CFR878.html">Part 878
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 878.4790  Powered surgical instrument for improvement in the appearance of cellulite.
                            </h3>
                            <p class="depth1"><em>(a)</em> Identification. A powered surgical instrument for improvement in the appearance of cellulite is a prescription device that is used for the controlled

release of subcutaneous tissue for improvement in the appearance of cellulite. The device consists of a cutting tool powered by a motor and a means for instrument guidance to control the areas of subcutaneous tissue cutting underneath the cellulite depressions or dimples.</p><p class="depth1"><em>(b)</em> Classification. Class II (special controls). The special controls for this device are:</p><p class="depth2"><em>(1)</em> Non-clinical testing must be performed to demonstrate that the device meets all design specifications and performance requirements, and to demonstrate durability and mechanical integrity of the device.</p><p class="depth2"><em>(2)</em> In vivo evaluation of the device must demonstrate device performance, including the safety of the release methodology and blood loss at the treatment sites.</p><p class="depth2"><em>(3)</em> All elements of the device that may contact the patient must be demonstrated to be biocompatible.</p><p class="depth2"><em>(4)</em> Electrical safety and electromagnetic compatibility of the device must be demonstrated.</p><p class="depth2"><em>(5)</em> The labeling must include a summary of in vivo evaluation data and all the device specific warnings, precautions, and/or contraindications.</p><p class="depth2"><em>(6)</em> Sterility and shelf-life testing for the device must demonstrate the sterility of patient contacting components and the shelf life of these components.
[79 FR 31861, June 3, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§.
          Code available <a href="https://github.com/anthonygarvan/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5
      </div>
    </div>
  </footer>
  </body>
</html>
